Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
111 ( (YI) ) has provided an update.
On February 11, 2025, 111, Inc. announced that it had regained compliance with the Nasdaq listing requirements, as confirmed by Nasdaq’s notification on February 10, 2025. The company achieved this compliance by maintaining a closing bid price of $1.00 per share or greater for ten consecutive business days, from January 24 to February 7, 2025. This development closes the matter with Nasdaq, potentially stabilizing the company’s market position and providing reassurance to its stakeholders.
More about 111
111, Inc. is a leading tech-enabled healthcare platform in China that aims to revolutionize the healthcare industry’s value chain through digital empowerment. The company offers pharmaceutical products and healthcare services via its online retail pharmacy, 1 Pharmacy, and its offline virtual pharmacy network. Additionally, it provides online healthcare services through 1 Clinic, its internet hospital. 111, Inc. also operates 1 Medicine, an online platform providing pharmacies with a vast selection of pharmaceutical products, and offers an omni-channel drug commercialization platform for strategic partners.
YTD Price Performance: 15.25%
Average Trading Volume: 33,020
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $59.79M
For a thorough assessment of YI stock, go to TipRanks’ Stock Analysis page.
